Common Stock, par value $0.001 per share
- Symbol
- VNRX
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 3.02 · 8-K
VolitionRx Limited
VNRXNYSE_AMERICANEQUITYCurrent
Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities Conversions of Note As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC, a Delaware limited liability company (“Lind”), a senior secured convertible promissory note…
Company context
We are a smaller reporting company and a non-accelerated filer, and we cannot be certain if the reduced disclosure requirements applicable to our filing status, as well as the exemption from the requirement to provide an auditor’s attestation report regarding the effectiveness of our internal controls, will make our common stock less attractive to investors.
Current securities
Registered securities in this filing
VolitionRx Limited · 8-K · Filed 2026-09-25
Disclosure sections
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item 3.02 Unregistered Sales of Equity Securities
Conversions of Note
As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC, a Delaware limited liability company (“Lind”), a senior secured convertible promissory note in the original principal amount of $2,400,000. In connection with its obligations under such note, (a) on September 18, 2026 the Company issued to Lind an aggregate of 698,113 shares of common stock to satisfy a $185,000 conversion obligation, and (b) on September 23, 2026 the Company issued to Lind an aggregate of 1,459,227 shares of common stock to satisfy a $340,000 conversion obligation. The offering and sale of the shares of common stock underlying the note were made in reliance on the exemption afforded by Section 3(a)(9) or alternatively Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Rule 506 of Regulation D under the Securities Act, and corresponding provisions of state securities or “blue sky” laws. The issuance of the shares of common stock was to an existing securityholder, did not involve any paid commissions, did not involve a public offering and was made without general solicitation or general advertising.